Can math make thyroid hormone therapy more precise?
NCT ID NCT07752277
First seen Aug 07, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This trial tests a new way to personalize the dose of levothyroxine, a thyroid hormone medication, for people who have had surgery for thyroid cancer. Using mathematical and statistical models, the approach aims to predict the best dose for each individual, potentially reducing side effects and improving treatment outcomes. The study includes adults aged 18-65 with advanced or metastatic thyroid cancer who are about to undergo total or near-total thyroidectomy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- levothyroxine sodium tablets (Euthyrox)
- What this could lead to
- If successful, this could lead to a personalized dosing strategy that helps thyroid cancer patients achieve better hormone balance with fewer side effects after surgery.
- What could go wrong
- The trial is relatively small and early, and the mathematical model may not work for everyone. Individual responses to the drug can vary, so the approach might not improve outcomes for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID AND OTHER ENDOCRINE GLAND CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, 310014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic test may spare patients from unnecessary thyroid surgery
- Can a new oral drug outsmart Radioiodine-Resistant thyroid cancer?
- Can an immune booster make radioiodine more effective against thyroid cancer?
- Hidden thyroid cancers may be more common in Graves' disease than thought
- Can AI help surgeons see thyroid cancer more clearly?
- Can a new PET tracer spot thyroid cancer recurrence more clearly?